- Home
- OPFI vs SENS Comparison
OPFI vs SENS Comparison
Compare OPFI & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPFI | SENS |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | United States | United States |
| Employees | 445 | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.2M | 308.5M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | OPFI | SENS |
|---|---|---|
| Price | $8.28 | $5.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $13.50 | ★ $22.70 |
| AVG Volume (30 Days) | 445.9K | ★ 482.8K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | ★ 3.01% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | $97.86 | $70.20 |
| Revenue Next Year | $12.64 | $59.10 |
| P/E Ratio | $67.57 | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $7.54 | $0.41 |
| 52 Week High | $14.63 | $8.75 |
Technical Indicators
Market Signals| Indicator | OPFI | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 33.21 | 28.26 |
| Support Level | N/A | $5.46 |
| Resistance Level | $10.93 | $8.55 |
| Average True Range (ATR) | 0.35 | 0.49 |
| MACD | -0.06 | -0.26 |
| Stochastic Oscillator | 12.99 | 7.85 |
Price Performance
Historical ComparisonAbout OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.